CanSino Biologics Catalyst Calendar
Proactively evaluate CanSino Biologics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of CanSino Biologics Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
30 Aug 2020 | Phase III Trial Initiation | Beijing Institute of Biotechnology; Bill & Melinda Gates Foundation; Canadian Center for Vaccinology; CanSino Biologics Inc; Dalhousie University; Hangzhou Tigermed Consulting Co Ltd; IWK Health Centre; Ministry of Health, Saudi Arabia | 300347; 6185 | COVID-19 [adenovirus type 5] Vaccine | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Clinical Trial Registry |
04 May 2020 | Phase I Trial Initiation | CanSino Biologics Inc; Henan Province Disease Prevention and Control Center; Tianjin University of Science and Technology | 6185 | pneumococcal (13-valent) vaccine | Infectious Disease | Streptococcal Infections; Unspecified Bacterial Infections | Clinical Trial Registry |
30 Apr 2020 | Phase I Trial Initiation | CanSino Biologics Inc; Henan Province Disease Prevention and Control Center | 6185 | (diphtheria + pertussis (acellular) + tetanus) vaccine | Infectious Disease | Diphtheria; Pertussis (Whooping Cough); Tetanus | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer